Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

WAVE

Waverley Pharma (WAVE)

Waverley Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:WAVE
DateTimeSourceHeadlineSymbolCompany
01/05/202410:08PR Newswire (Canada)Waverley Pharma Business UpdateTSXV:WAVEWaverley Pharma Inc
23/11/202309:00PR Newswire (Canada)Waverley Pharma Announces Changes to Board of DirectorsTSXV:WAVEWaverley Pharma Inc
03/08/202306:37PR Newswire (Canada)Waverley Pharma Business UpdateTSXV:WAVEWaverley Pharma Inc
20/03/202322:55PR Newswire (Canada)Waverley Pharma Provides Business UpdateTSXV:WAVEWaverley Pharma Inc
11/01/202323:55PR Newswire (Canada)Waverley Pharma Provides Update on its PARP-1 Inhibitor ProgramTSXV:WAVEWaverley Pharma Inc
05/08/202122:05PR Newswire (Canada)Waverley Pharma Announces $3,000,000 Credit FacilityTSXV:WAVEWaverley Pharma Inc
27/05/202122:05PR Newswire (Canada)Waverley Pharma Announces Successful Tender Award for Pemetrexed with NHS EnglandTSXV:WAVEWaverley Pharma Inc
19/01/202100:40PR Newswire (Canada)Waverley Pharma Announces Successful Tender Award for Capecitabine with NHS ScotlandTSXV:WAVEWaverley Pharma Inc
13/11/202004:04PR Newswire (Canada)Waverley Pharma Announces Tentative ANDA Approval for Pemetrexed in the United StatesTSXV:WAVEWaverley Pharma Inc
23/09/202022:20PR Newswire (Canada)Waverley Pharma Announces Listing on the Frankfurt Stock Exchange (FSE: 5GZ)TSXV:WAVEWaverley Pharma Inc
09/09/202000:13PR Newswire (Canada)Waverley Pharma Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the Un...TSXV:WAVEWaverley Pharma Inc
25/08/202022:15PR Newswire (Canada)Waverley Pharma Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in ItalyTSXV:WAVEWaverley Pharma Inc
30/07/202022:25PR Newswire (Canada)Waverley Pharma Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European CountriesTSXV:WAVEWaverley Pharma Inc
25/06/202022:15PR Newswire (Canada)Waverley Pharma Announces Collaboration with Dr. David E. Herbert and the University of Manitoba for the Development of a Syn...TSXV:WAVEWaverley Pharma Inc
29/04/202006:53PR Newswire (Canada)Waverley Pharma Announces Reliance on Relief from Filing Requirements for Annual Financial StatementsTSXV:WAVEWaverley Pharma Inc
04/02/202000:15PR Newswire (Canada)Waverley Pharma Announces Appointment of New President and CEOTSXV:WAVEWaverley Pharma Inc
09/01/202009:09PR Newswire (Canada)Waverley Pharma Announces Executive Leadership ChangesTSXV:WAVEWaverley Pharma Inc
18/12/201900:00PR Newswire (Canada)Waverley Pharma Announces Grant of Marketing Authorization in the United Kingdom for ErlotinibTSXV:WAVEWaverley Pharma Inc
11/03/201923:25PR Newswire (Canada)Waverley Pharma Provides Market Update and Fiscal 2018 Preliminary RevenueTSXV:WAVEWaverley Pharma Inc
19/12/201800:25PR Newswire (Canada)Waverley Pharma Announces Distribution Agreement and First Sale of Generic Oncology Products in the United KingdomTSXV:WAVEWaverley Pharma Inc
23/07/201822:35PR Newswire (Canada)Waverley Pharma Announces Resignation of CEO and Appointment of New CEOTSXV:WAVEWaverley Pharma Inc
27/06/201822:35PR Newswire (Canada)Waverley Pharma Announces Filing of Two Abbreviated New Drug Applications in the United StatesTSXV:WAVEWaverley Pharma Inc
25/06/201822:30PR Newswire (Canada)Waverley Pharma Announces Acquisition of two Generic Oncology Products Currently Marketed in the United KingdomTSXV:WAVEWaverley Pharma Inc
17/04/201822:30PR Newswire (Canada)Waverley Pharma Announces Filing of its Second Marketing Authorization Application in Select European Union CountriesTSXV:WAVEWaverley Pharma Inc
13/03/201800:00PR Newswire (Canada)Waverley Pharma Announces Filing of Marketing Authorization Application in Select European Union CountriesTSXV:WAVEWaverley Pharma Inc
28/10/201701:01PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - WAVE (anciennement BUFF.P)TSXV:WAVEWaverley Pharma Inc
28/10/201700:59PR Newswire (Canada)IIROC Trading Resumption - WAVE (Formerly BUFF.P)TSXV:WAVEWaverley Pharma Inc
 Showing the most relevant articles for your search:TSXV:WAVE

Your Recent History

Delayed Upgrade Clock